Literature DB >> 29709207

Viral Strategies for Targeting the Central and Peripheral Nervous Systems.

Claire N Bedbrook1, Benjamin E Deverman1, Viviana Gradinaru1.   

Abstract

Recombinant viruses allow for targeted transgene expression in specific cell populations throughout the nervous system. The adeno-associated virus (AAV) is among the most commonly used viruses for neuroscience research. Recombinant AAVs (rAAVs) are highly versatile and can package most cargo composed of desired genes within the capsid's ∼5-kb carrying capacity. Numerous regulatory elements and intersectional strategies have been validated in rAAVs to enable cell type-specific expression. rAAVs can be delivered to specific neuronal populations or globally throughout the animal. The AAV capsids have natural cell type or tissue tropism and trafficking that can be modified for increased specificity. Here, we describe recently engineered AAV capsids and associated cargo that have extended the utility of AAVs in targeting molecularly defined neurons throughout the nervous system, which will further facilitate neuronal circuit interrogation and discovery.

Entities:  

Keywords:  AAV; CREATE; adeno-associated virus; cell type specificity; gene transfer; systemic delivery; viral capsid engineering

Mesh:

Year:  2018        PMID: 29709207     DOI: 10.1146/annurev-neuro-080317-062048

Source DB:  PubMed          Journal:  Annu Rev Neurosci        ISSN: 0147-006X            Impact factor:   12.449


  53 in total

Review 1.  Tutorial: practical considerations for tissue clearing and imaging.

Authors:  Kurt R Weiss; Fabian F Voigt; Douglas P Shepherd; Jan Huisken
Journal:  Nat Protoc       Date:  2021-05-21       Impact factor: 13.491

Review 2.  Whole-Brain Analysis of Cells and Circuits by Tissue Clearing and Light-Sheet Microscopy.

Authors:  Tomoyuki Mano; Alexandre Albanese; Hans-Ulrich Dodt; Ali Erturk; Viviana Gradinaru; Jennifer B Treweek; Atsushi Miyawaki; Kwanghun Chung; Hiroki R Ueda
Journal:  J Neurosci       Date:  2018-10-31       Impact factor: 6.167

Review 3.  Emerging antisense oligonucleotide and viral therapies for amyotrophic lateral sclerosis.

Authors:  Cindy V Ly; Timothy M Miller
Journal:  Curr Opin Neurol       Date:  2018-10       Impact factor: 5.710

Review 4.  CRISPR, Prime Editing, Optogenetics, and DREADDs: New Therapeutic Approaches Provided by Emerging Technologies in the Treatment of Spinal Cord Injury.

Authors:  Vera Paschon; Felipe Fernandes Correia; Beatriz Cintra Morena; Victor Allisson da Silva; Gustavo Bispo Dos Santos; Maria Cristina Carlan da Silva; Alexandre Fogaça Cristante; Stephanie Michelle Willerth; Florence Evelyne Perrin; Alexandre Hiroaki Kihara
Journal:  Mol Neurobiol       Date:  2020-01-11       Impact factor: 5.590

5.  Modulation of Sialic Acid Dependence Influences the Central Nervous System Transduction Profile of Adeno-associated Viruses.

Authors:  Blake H Albright; Katherine E Simon; Minakshi Pillai; Garth W Devlin; Aravind Asokan
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

Review 6.  Crossing the blood-brain barrier with AAV vectors.

Authors:  Dan Liu; Mingyang Zhu; Yuqian Zhang; Yong Diao
Journal:  Metab Brain Dis       Date:  2020-11-17       Impact factor: 3.584

7.  Synaptic Specificity and Application of Anterograde Transsynaptic AAV for Probing Neural Circuitry.

Authors:  Brian Zingg; Bo Peng; Junxiang Huang; Huizhong W Tao; Li I Zhang
Journal:  J Neurosci       Date:  2020-03-20       Impact factor: 6.167

8.  Translating Insights From Optogenetics To Therapies For Parkinson's Disease.

Authors:  Aryn H Gittis; Eric A Yttri
Journal:  Curr Opin Biomed Eng       Date:  2018-09-12

Review 9.  Tissue clearing and its applications in neuroscience.

Authors:  Hiroki R Ueda; Ali Ertürk; Kwanghun Chung; Viviana Gradinaru; Alain Chédotal; Pavel Tomancak; Philipp J Keller
Journal:  Nat Rev Neurosci       Date:  2020-02       Impact factor: 34.870

10.  Optimizing Nervous System-Specific Gene Targeting with Cre Driver Lines: Prevalence of Germline Recombination and Influencing Factors.

Authors:  Lin Luo; Mateusz C Ambrozkiewicz; Fritz Benseler; Cui Chen; Emilie Dumontier; Susanne Falkner; Elisabetta Furlanis; Andrea M Gomez; Naosuke Hoshina; Wei-Hsiang Huang; Mary Anne Hutchison; Yu Itoh-Maruoka; Laura A Lavery; Wei Li; Tomohiko Maruo; Junko Motohashi; Emily Ling-Lin Pai; Kenneth A Pelkey; Ariane Pereira; Thomas Philips; Jennifer L Sinclair; Jeff A Stogsdill; Lisa Traunmüller; Jiexin Wang; Joke Wortel; Wenjia You; Nashat Abumaria; Kevin T Beier; Nils Brose; Harold A Burgess; Constance L Cepko; Jean-François Cloutier; Cagla Eroglu; Sandra Goebbels; Pascal S Kaeser; Jeremy N Kay; Wei Lu; Liqun Luo; Kenji Mandai; Chris J McBain; Klaus-Armin Nave; Marco A M Prado; Vania F Prado; Jeffrey Rothstein; John L R Rubenstein; Gesine Saher; Kenji Sakimura; Joshua R Sanes; Peter Scheiffele; Yoshimi Takai; Hisashi Umemori; Matthijs Verhage; Michisuke Yuzaki; Huda Yahya Zoghbi; Hiroshi Kawabe; Ann Marie Craig
Journal:  Neuron       Date:  2020-02-05       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.